acquired<\/a> a California-based peptide facility. At the time, CEO Andrew Dudum called peptide demand “future-facing innovation.” <\/p>\n“Many use cases have yet to be launched,” said Dudum. “Peptide innovation is at the forefront of so many categories we’re excited to start offering.”<\/p>\n
Following Kennedy’s announcement on Wednesday, Hims Chief Medical Officer Dr. Patrick Carroll applauded the news as a move away from the “gray market,” saying the goal is to bring peptide therapy into regulated, physician-led care.<\/p>\n
“Our medical team believes certain peptide therapies hold meaningful potential in helping Americans live healthier lives, and we are actively exploring how to expand access in a way that will be aligned with FDA guidance,” Carroll said.<\/p>\n
Leerink Partners called the news that the FDA will review peptides for the compounding list a positive outcome that could give Hims a clearer regulatory path to scale peptide therapies. Even so, the firm said it will take time for peptides to boost the company’s bottom line.<\/p>\n
“This would not immediately translate into revenue, but would seemingly be a growth avenue that HIMS would push hard on,” said Leerink analyst Michael Cherny, who has a hold-equivalent rating on the stock and a $25 price target. The stock was trading at around $26 a share Thursday.<\/p>\n
For now the opportunity is still early, and clinical evidence supporting many peptide therapies is still limited.<\/p>\n
Of the dozen peptides listed by Kennedy for consideration on the compounding bulk list, one \u2014 MK-677 \u2014 is often treated as an illegal drug when sold for human consumption. The growth hormone has also been banned by the World Anti-Doping Agency. <\/p>\n
Other peptides on the list, such as GHK-Cu and Semax, which are used for cosmetic or cognitive enhancement, are generally viewed as less controversial, but still lack robust scientific backing.<\/p>\n
Kennedy \u2014 who has supported many medical treatments and food options outside of those backed by mainstream science \u2014 was asked about his plans for expanding peptide therapies during a House Ways and Means Committee hearing Thursday.<\/p>\n
“Peptides were not supposed to be regulated,” Kennedy said, arguing the Biden administration restricted the use of peptides due to safety concerns that he considers unfounded. <\/p>\n
The FDA process is just beginning, and the July meeting will be advisory only, so change is not expected to be immediate. <\/p>\n
Even so, investors are already focusing on what replaces GLP-1 as a growth driver for Hims, and peptides are emerging as one of the clearest candidates so far.<\/p>\n
Choose CNBC as your preferred source on Google and never miss a moment from the most trusted name in business news.<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"Piotr Swat | Lightrocket | Getty Images As its high-margin compounded GLP-1 business evolves, Hims & Hers Health…\n","protected":false},"author":2,"featured_media":589092,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[27],"tags":[1071,28,122,2538,2601,27681,111,788],"class_list":["post-589091","post","type-post","status-publish","format-standard","has-post-thumbnail","category-business","tag-breaking-news-politics","tag-business","tag-business-news","tag-food-and-drink","tag-health-care-industry","tag-hims-hers-health-inc","tag-politics","tag-robert-f-kennedy-jr"],"_links":{"self":[{"href":"https:\/\/www.newsbeep.com\/us\/wp-json\/wp\/v2\/posts\/589091","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.newsbeep.com\/us\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.newsbeep.com\/us\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/us\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/us\/wp-json\/wp\/v2\/comments?post=589091"}],"version-history":[{"count":0,"href":"https:\/\/www.newsbeep.com\/us\/wp-json\/wp\/v2\/posts\/589091\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/us\/wp-json\/wp\/v2\/media\/589092"}],"wp:attachment":[{"href":"https:\/\/www.newsbeep.com\/us\/wp-json\/wp\/v2\/media?parent=589091"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.newsbeep.com\/us\/wp-json\/wp\/v2\/categories?post=589091"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.newsbeep.com\/us\/wp-json\/wp\/v2\/tags?post=589091"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}